Inspire Investing’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-42,947
Closed -$392K 930
2025
Q2
$392K Sell
42,947
-247
-0.6% -$1.82K 0.04% 441
2025
Q1
$343K Sell
43,194
-32,119
-43% -$235K 0.04% 586
2024
Q4
$409K Buy
75,313
+17,541
+30% +$107K 0.05% 359
2024
Q3
$417K Buy
57,772
+25,139
+77% +$230K 0.04% 372
2024
Q2
$354K Buy
32,633
+13,399
+70% +$172K 0.04% 427
2024
Q1
$360K Buy
19,234
+1,652
+9% +$38.1K 0.04% 468
2023
Q4
$381K Buy
17,582
+2,533
+17% +$50.2K 0.04% 755
2023
Q3
$310K Buy
15,049
+1,169
+8% +$33.8K 0.04% 429
2023
Q2
$653K Buy
13,880
+622
+5% +$30.9K 0.08% 244
2023
Q1
$556K Buy
13,258
+6,809
+106% +$293K 0.07% 207
2022
Q4
$246K Buy
6,449
+848
+15% +$32.4K 0.03% 346
2022
Q3
$219K Sell
5,601
-932
-14% -$36K 0.03% 335
2022
Q2
$211K Sell
6,533
-20,891
-76% -$700K 0.03% 690
2022
Q1
$908K Buy
27,424
+21,531
+365% +$809K 0.11% 177
2021
Q4
$251K Buy
5,893
+745
+14% +$31.2K 0.03% 410
2021
Q3
$228K Buy
5,148
+1,122
+28% +$51.5K 0.03% 641
2021
Q2
$229K Sell
4,026
-10,643
-73% -$752K 0.03% 574
2021
Q1
$1.1M Buy
14,669
+12,251
+507% +$1M 0.17% 124
2020
Q4
$209K Buy
+2,418
New +$178K 0.05% 605
2018
Q1
Sell
-351
Closed -$58K 601
2017
Q4
$58K Buy
+351
New +$34K 0.05% 412

Other funds holding SAGE